Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by McGuire Investment Group LLC

McGuire Investment Group LLC grew its position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOMGet Rating) by 0.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 525,886 shares of the company’s stock after acquiring an additional 1,900 shares during the quarter. McGuire Investment Group LLC owned about 3.62% of Global X Genomics & Biotechnology ETF worth $6,426,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Tcwp LLC acquired a new stake in shares of Global X Genomics & Biotechnology ETF in the first quarter valued at approximately $32,000. Hazlett Burt & Watson Inc. acquired a new stake in shares of Global X Genomics & Biotechnology ETF during the first quarter worth $40,000. Simplex Trading LLC lifted its holdings in shares of Global X Genomics & Biotechnology ETF by 1,594.9% during the first quarter. Simplex Trading LLC now owns 8,034 shares of the company’s stock worth $120,000 after purchasing an additional 7,560 shares during the period. Main Management LLC acquired a new stake in shares of Global X Genomics & Biotechnology ETF during the fourth quarter worth $137,000. Finally, Capital Analysts LLC acquired a new stake in shares of Global X Genomics & Biotechnology ETF during the first quarter worth $162,000.

Global X Genomics & Biotechnology ETF Price Performance

Shares of NASDAQ GNOM traded down $0.30 during mid-day trading on Friday, hitting $12.27. 898 shares of the company were exchanged, compared to its average volume of 147,048. The stock has a 50 day simple moving average of $14.38 and a 200-day simple moving average of $13.61. Global X Genomics & Biotechnology ETF has a 1-year low of $10.48 and a 1-year high of $24.01.

Global X Genomics & Biotechnology ETF Company Profile

(Get Rating)

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.

Featured Articles

Institutional Ownership by Quarter for Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Receive News & Ratings for Global X Genomics & Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.